LATEST ARTICLES

Vivek Ramaswamy’s parent company, Roivant Sciences, inked a development deal with Swiss-based AstraZeneca.   The deal seems consistent with Ramaswamy’s business model—acquire cast-off compounds from...
WalletHub, a financial website, recently examined the quarterly filings of hedge funds to determine which stocks they’re buying the most. The idea is...
Shortly after Rhythm Pharmaceuticals Inc. made its public debut on the Nasdaq Exchange, Pfizer has snapped up a small percentage of the company focused...